Textmunication Holdings, Inc. Appoints former Philips Electronics C-Level Executive as Technical Advisor
PLEASANT HILL, Calif., April 12, 2017 /PRNewswire/ — Textmunication Holdings, Inc. (TXHD), a cloud-based mobile SMS marketing platform provider, announced on March 13, 2017 in an 8k filing the addition of Rajeev Varshneya as Technical Advisor.
Mr. Varshneya’s roles at Philips included CEO of Philips Software Center, VP of Product Strategy, Engineering and Operations and SVP of Technology, Product Development and Strategy. He has also led numerous technology start-ups and is actively involved in government contracting with leading systems integrators.
CEO Wais Asefi stated: “Mr. Varshneya’s believes in the Textmunication technology blueprint and has explained, in-depth where he sees the mobile marketing sector evolving and how Textmunication will play a major role.”
Rajeev Varshneya, Technical Advisor to Textmunication Stated:
“Textmunication is at the heart of social interaction and modern means of business communication. The amount of digital communication we will do, in private and in business, is likely to exponentially grow based on text messaging – far surpassing any other mechanism (calls, emails etc.). This is a sweet spot that has incredible future business potential. Textmunication was a pioneer of text messaging campaigns before market acceptance. I’m pleased to see the evolution of Textmunication’s technology and vision for scaling mobile marketing to the masses.
The Textmunication SMS platform will undergo very rapid changes in the short and mid-term. It will become ubiquitous in the way it’s incorporated into existing corporate solutions for businesses as a white label option and, at the same time, organizations wanting to keep IT out of their areas of expertise will use subscription to the platform like never before. To achieve this, the Textmunication platform will move to a true multi-tenancy model in which businesses benefit from the existing domain knowledge Textmunication has access to and achieve a fast time to market and money. Others will benefit from the exceptionally intuitive user experience the next generation platform will achieve along with mobile device access and ‘anywhere, anytime access and communication’ paradigm.
Textmunication will also work with businesses to harness additional value from the data they have in the system for business optimization and business expansion. The platform is not just about text messaging, it is about business maximization by super-fast reach to the clients and engaging them in an enticing manner. Textmunication expects to be a “partner of choice” based on its technology roadmap and solution offering. Current and future partnerships will appreciate our new software platform bringing both new functionality and scalability.
I joined Textmunication because I believe in its vision for developing leading SMS technology in a rapidly growing sector. Textmunication is positioned to be the SMS leader through innovation and collaboration with its partners and vast network. Hiring top-notch architects and developers was a huge step for the company and will elevate Textmunication with a state-of-the-art software platform capable of serving thousands of clients and millions of end-users. I have been associated with companies similar to Textmunication’s growth path and truly believe this company is positioned to do great things.
I am excited about this journey.”
Text TXHD to shortcode 87365 to sign-up for news alerts and announcements via SMS.
About Textmunication Holdings, Inc.
Textmunication is an online mobile marketing platform service provider that helps health clubs, martial arts studios, salons and healthcare firms communicate with their members by allowing them to build loyalty, engage member retention, and create new business through a non-intrusive, value added medium. Textmunication connects members to the content they desire through any mobile device for health clubs and salon events, as well as promotions. Clients can send the most up-to-date offers, discounts, member alerts, events, PT schedules, or any other personalized campaign. www.textmunication.com
Text DEMO to shortcode 87365 to sign up for a demonstration on our SMS solution.
Safe Harbor Provision:
Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forward-looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on any forward-looking statements in this press release as they reflect Textmunication Holdings’ current expectations with respect to future events and are subject to risks and uncertainties that may cause actual results to differ materially from those contemplated. Potential risks and uncertainties include, but are not limited to, the risks described in Textmunication Holdings’ filings with the Securities and Exchange Commission. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and any document referred to in this press release.
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/textmunication-holdings-inc-appoints-former-philips-electronics-c-level-executive-as-technical-advisor-300438743.html
16MARTextmunication Holdings, Inc. Builds For The Future
11DECSPECIAL LETTER TO SHAREHOLDERS
17MARAspire Consulting Group Executes on It’s Strategic Roadmap
Safe Starting Dose for First-In-Human Studies Defined, Clinical Development Stage Commences
MELBOURNE, AUSTRALIA -- (Marketwired) -- 04/27/17 -- Propanc Biopharma, Inc. (OTCQB: PPCH)(OTCQB: PPCHD) ("Propanc" or "the Company"), an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced the successful completion of the GLP-compliant, 28-day repeat-dose toxicity study for its lead product, PRP. Importantly, there were no major toxicological findings after administration of PRP by intravenous injection once daily throughout the study period. PRP is a combination of pancreatic proenzymes trypsinogen and chymotrypsinogen in solution, for once daily intravenous administration.
The GLP-compliant study was conducted by the Company's contract research partner, vivoPharm Pty Ltd, in Melbourne, Australia.
"We are delighted to have completed this important milestone, which is pivotal for supporting a clinical trial application in the UK, which we expect to submit later this year," said James Nathanielsz, Propanc's Chief Executive Officer. "We have now officially entered the clinical development stage for our lead product, PRP, which represents an exciting new therapeutic approach for the treatment and prevention of metastatic cancer."
"Now that we have completed the 28-day toxicity study, I believe we have sufficient data to support a safe starting dose for First-In-Human studies, initially targeting patients suffering from solid tumors," said Professor Klaus Kutz, Propanc's Chief Medical Officer. "My immediate objective is to assist our manufacturing partner, Q Biologicals, undertake the steps necessary to complete the GMP product manufacture of PRP, which forms a key part of our IMPD (Investigational Medicinal Product Dossier)."
These types of studies are key to the developmental process for new therapeutic agents prior to clinical testing in humans and have been already discussed in detail at a scientific advice meeting with the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, last year.
Currently progressing towards First-In-Human studies, PRP aims to prevent tumor recurrence and metastasis from solid tumors. Eighty percent of all cancers are solid tumors and metastasis is the main cause of patient death from cancer. The Company's initial target patient populations are pancreatic, ovarian and colorectal cancers.
To view Propanc's "Mechanism of Action" video on anti-cancer product candidate, PRP, please click on the following link: http://www.propanc.com/news-media/video
To be added to Propanc's email distribution list, please email PPCH@kcsa.com with "Propanc" in the subject line.
Propanc is developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ pancreatic proenzymes, which are inactive precursors of enzymes. In the near term, we intend to target patients with limited remaining therapeutic options for the treatment of solid tumors. In future, we intend to develop our lead product to treat (i) early stage cancer and (ii) pre-cancerous diseases and (iii) as a preventative measure for patients at risk of developing cancer based on genetic screening. For more information, visit: www.propanc.com.
All statements other than statements of historical fact contained herein are "forward-looking statements" for purposes of federal and state securities laws. Forward-looking statements may include the words "may," "will," "estimate," "intend," "continue," "believe," "expect," "plan" or "anticipate" and other similar words. Although we believe that the expectations reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties including those regarding our earnings, revenues and financial condition, our ability to implement our plans, strategies and objectives for future operations, our ability to execute on proposed new products, services or development thereof, our ability to establish and maintain the proprietary nature of our technology through the patent process, our ability to license from others patents and patent applications, if necessary, to develop certain products, our ability to implement our long range business plan for various applications of our technology, our ability to enter into agreements with any necessary manufacturing, marketing and/or distribution partners for purposes of commercialization, the results of our clinical research and development, competition in the industry in which we operate, overall market conditions, and any statements or assumptions underlying any of the foregoing. Other risks, uncertainties and factors that could cause actual results to differ materially from those projected may be described from time to time in reports we file with the Securities and Exchange Commission, including our reports on Forms 10-K, 10-Q and 8-K. We do not intend, and undertake no obligation, to update any forward-looking statement contained herein, except as required by law.
KCSA Strategic Communications
Philip Carlson / Elizabeth Barker
Jon Goldberg / Lisa Lipson
Source: Propanc Biopharma, Inc.
Released April 27, 2017
Apr 25, 2017 Back to NewsNew York, NY. -- Sparta Commercial Services, Inc. (SRCO), through its subsidiary, iMobile Solutions, Inc., an emerging leader in the development, management, and servicing of custom mobile apps for vehicle dealers from Harley-Davidson® to John Deere, reported today that country, golf, and other member-based clubs continue to select iMobileApp for their digital marketing and communication needs.
Through offering the design of customized mobile applications unique to each club’s needs, prominently displaying their individual branding, iMobileApp provides clubs technology with features that benefit both members and staff, while still promoting the time honored traditions that long-time members expect.
Clubs of all kinds are finding that mobile applications represent a highly effective marketing tool that encourages and promotes member interaction as evidenced by the additional club apps launched by iMobileApp listed below:
The Oaks and Candia Woods, golf clubs, in New Hampshire,
Inverness Country Club, a golf, tennis, aquatic, fitness & social club, in Alabama,
Holly Hills Country Club, a golf, swimming, tennis & social club, in Maryland,
Chanon Zimmerman, Marketing & Communications Director of Holly Hills Country Club, said, "The app is an effective marketing tool and our members love it. There are so many features but we especially love the push notification feature. It’s much more cost effective compared to text marketing and has so many more capabilities. Making simple and complex changes to the app is a breeze with their user-friendly dashboard and a customer service team that aims to please. My only regret, I wish we had done it sooner.”
Watch our iMobileApp Restaurant and Grocery Store videos available on YouTube: